Fmoc-S-tert-butyl-L-cysteine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-S-tert-butyl-L-cysteine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-003837
CAS number
67436-13-9
Molecular Formula
C22H25NO4S
Molecular Weight
399.50
Fmoc-S-tert-butyl-L-cysteine
IUPAC Name
(2R)-3-tert-butylsulfanyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
Synonyms
Fmoc-L-Cys(tBu)-OH; Fmoc-(R)-2-amino-3-(S-tert-butyl)propanoic acid; (2R)-3-tert-butylsulfanyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
Appearance
White powder
Purity
≥ 99% (HPLC)
Density
1.237±0.06 g/cm3
Melting Point
133-147 °C
Boiling Point
603.4±55.0 °C
Storage
Store at 2-8 °C
InChI
InChI=1S/C22H25NO4S/c1-22(2,3)28-13-19(20(24)25)23-21(26)27-12-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,18-19H,12-13H2,1-3H3,(H,23,26)(H,24,25)/t19-/m0/s1
InChI Key
IXAYZHCPEYTWHW-IBGZPJMESA-N
Canonical SMILES
CC(C)(C)SCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Fmoc-S-tert-butyl-L-cysteine is a protected amino acid derivative commonly used in peptide synthesis and research. Here are some key applications of Fmoc-S-tert-butyl-L-cysteine:

Solid-Phase Peptide Synthesis: Fmoc-S-tert-butyl-L-cysteine is frequently used in solid-phase peptide synthesis (SPPS) to construct peptides that retain the thiol functionality of cysteine. The Fmoc group protects the amino group during the synthesis, while the tert-butyl group safeguards the thiol side chain. This ensures that reactive groups are preserved and can be utilized for further modifications post-synthesis.

Drug Discovery: In drug discovery, Fmoc-S-tert-butyl-L-cysteine can be incorporated into peptide sequences to study the structure-activity relationship of cysteine-containing peptides. Its use allows researchers to systematically investigate the impact of cysteine modifications on binding affinity and biological activity. This can lead to the development of novel peptide therapeutics with improved efficacy and stability.

Bioconjugation: The protected thiol group in Fmoc-S-tert-butyl-L-cysteine allows for site-specific bioconjugation applications. After peptide synthesis, the tert-butyl group can be removed to reveal the free thiol, which can then be used to form disulfide bonds or to attach other functional molecules, such as fluorophores or drugs. This is valuable in the design of multifunctional biomolecules for imaging or therapeutic uses.

Protein Engineering: Fmoc-S-tert-butyl-L-cysteine is utilized in protein engineering to incorporate cysteine residues into specific positions of protein sequences. The protection groups ensure targeted introduction of cysteine, allowing precise manipulation of protein structure and function. This approach can be used to study protein folding, stability, and interactions, offering insights into fundamental biological processes and enabling the design of engineered proteins with desirable traits.

1.Side-chain anchoring strategy for solid-phase synthesis of peptide acids with C-terminal cysteine.
Barany G1, Han Y, Hargittai B, Liu RQ, Varkey JT. Biopolymers. 2003;71(6):652-66.
Many naturally occurring peptide acids, e.g., somatostatins, conotoxins, and defensins, contain a cysteine residue at the C-terminus. Furthermore, installation of C-terminal cysteine onto epitopic peptide sequences as a preliminary to conjugating such structures to carrier proteins is a valuable tactic for antibody preparation. Anchoring of N(alpha)-Fmoc, S-protected C-terminal cysteine as an ester onto the support for solid-phase peptide synthesis is known to sometimes occur in low yields, has attendant risks of racemization, and may also result in conversion to a C-terminal 3-(1-piperidinyl)alanine residue as the peptide chain grows by Fmoc chemistry. These problems are documented for several current strategies, but can be circumvented by the title anchoring strategy, which features the following: (a). conversion of the eventual C-terminal cysteine residue, with Fmoc for N(alpha)-amino protection and tert-butyl for C(alpha)-carboxyl protection, to a corresponding S-xanthenyl ((2)XAL(4)) preformed handle derivative; and (b).
Online Inquiry
Verification code
Inquiry Basket